Literature DB >> 16124794

Binuclear complexes of Co(III) containing extended conjugated bis(catecholate) ligands.

Yusaku Suenaga1, Cortlandt G Pierpont.   

Abstract

Binuclear complexes of cobalt(III) have been prepared with 3,3',4,4'-tetrahydroxy-benzaldazine (H4thB), 3,3',4,4'-tetrahydroxy-5,5'-dimethoxybenzaldazine (H4thM), and 3,3',4,4'-tetrahydroxydimethylbenzaldazine (H4thA) as bis(catecholate) ligands that link metal ions separated by 16 A through a conjugated bridge. In one case, [Co2(bpy)4(thM)]2+, stereodynamic properties observed in solution by 1H NMR are associated with valence tautomerism, with formation of a labile hs-Co(II) species by electron transfer from the catecholate regions of the bridge. Electrochemical oxidation of the complexes occurs at the bridges as two closely spaced one-electron couples. Chemical oxidation of [Co2(bpy) 4(thB)]2+ with Ag+ is observed to occur as a two-electron process forming [Co2(bpy) 4(thB(SQ,SQ))]4+. Attempted crystallization in the presence of air was observed to result in formation of the [Co(bpy)2(BACat)]+ (H2BACat, 3,4-dihydroxybenzaldehyde) cation by aerobic oxidation. Structural characterization is provided for the H4thM ligand and [Co(bpy)2(BACat)](BF4).

Entities:  

Year:  2005        PMID: 16124794     DOI: 10.1021/ic050250m

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  2 in total

1.  Dinuclear adducts of di-o-iminoquinone ligands with CoII diketonates: computational insights into two-step valence tautomeric rearrangements.

Authors:  A A Starikova; А G Starikov; V I Minkin
Journal:  J Mol Model       Date:  2017-10-09       Impact factor: 1.810

2.  Platinum(ii) complexes of mixed-valent radicals derived from cyclotricatechylene, a macrocyclic tris-dioxolene.

Authors:  Jonathan J Loughrey; Nathan J Patmore; Amgalanbaatar Baldansuren; Alistair J Fielding; Eric J L McInnes; Michaele J Hardie; Stephen Sproules; Malcolm A Halcrow
Journal:  Chem Sci       Date:  2015-08-20       Impact factor: 9.825

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.